Clinical trials
Cardiotoxicity trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 11 |
| Terminated | 11 |
| Active, not recruiting | 6 |
| Not yet recruiting | 4 |
| Unknown status | 4 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 10 |
| Children's Oncology Group | 4 |
| Washington University School of Medicine | 4 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National Cancer Institute (NCI) | 3 |
| Cedars-Sinai Medical Center | 2 |
| Mayo Clinic | 2 |
| SWOG Cancer Research Network | 2 |
| University of Minnesota | 2 |
| University of Virginia | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 68 |
| Breast Neoplasms | 29 |
| Neoplasms | 14 |
| Heart Failure | 11 |
| Lymphoma | 10 |
| Cardiovascular Diseases | 7 |
| Lung Neoplasms | 5 |
| Cardiomyopathies | 4 |
| Sarcoma | 4 |
| Leukemia | 3 |
Trials
Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.